Symptoms and Signs: Clinical Trials

4 trials for Symptoms and Signs, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 32Completed 2
Phase 11Completed 1

Follow Symptoms and Signs: new trials by email Literature Review of Symptoms and Signs trials Research Report on Symptoms and Signs

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease
Chazhu Xiaozhi decoction, Control placebo - Hepatic Steatosis, Symptoms and Signs
Phase 2CompletedShanghai Municipal Hospital of Traditional Chinese Medicine702024-07-172025-04-03
Title: Leveraging Technology to Address Health Outcomes of Cancer Survivors
POSTHOC app - Survivorship, Cancer
Phase 1 / Phase 2CompletedUniversity of Maryland, Baltimore512024-03-052026-02-06
Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III
Chlorpheniramine Maleate 0.4% Nasal Spray, Placebo - COVID-19, Symptoms and Signs
Phase 2 / Phase 3CompletedDr. Ferrer BioPharma1572022-07-272023-06-02
Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I
Chlorpheniramine Maleate 1% Nasal Spray, Placebo - COVID-19, Symptoms and Signs
Phase 2 / Phase 3CompletedDr. Ferrer BioPharma1012021-12-072023-03-23

Narrower conditions

Signs and Symptoms (4)  ·  COVID-19 (2)  ·  Coronavirus Infections (2)  ·  Fatty Liver (1)  ·  Motor Activity (1)  ·  Neoplasms (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Coronaviridae Infections (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Behavior (1)  ·  Digestive System Diseases (1)  ·  Liver Diseases (1)

Interventions

Chlorpheniramine (2)  ·  Nasal Sprays (2)

Sponsors

Dr. Ferrer BioPharma (2)  ·  Shanghai Municipal Hospital of Traditional Chinese Medicine (1)  ·  University of Maryland, Baltimore (1)

Countries

Honduras (2)  ·  China (1)  ·  United States (1)

Top investigators

Amber Kleckner, PhD (1)

Results publications

PMID 39235855, PMID 41307872

NIH funding

75N91021C00019-0-9999-1 (1)